⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

CDNA

CareDx, Inc.

Healthcare · Diagnostics & Research

50.03USD

-0.2800 (-0.56%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY321.8M280.3M333.8M379.8M495.1M524.0M
Q179.4M77.3M72.0M84.7M117.7M—
Q280.6M70.3M92.3M86.7M131.9M—
Q379.4M67.2M82.9M100.1M121.8M—
Q482.4M*65.6M*86.6M*108.4M*123.6M—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY-1.44-3.54.930-.4001.201.33
Q1-.370-.440-.380-.190.050—
Q2-.410-.460-.090-.1602.07—
Q3-.320-.430-.200.030.251—
Q4-.344*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

-2.20*
1.55*
-.077*
.241
—